European Market Report Suite for Urological Devices 2016 – MedSuite

European Market Report Suite for Urological Devices 2016 – MedSuite

0

  • Year: 2016
  • Scope: 2012-2022
  • Region: Europe
  • Published Date: 09/01/2016
  • Pages: 695
  • Type: MedSuite

The European urology market included devices for urinary incontinence, benign prostate hyperplasia (BPH), erectile dysfunction (ED), brachytherapy, nephrostomy, stone management and urological endoscopes. This market includes the segments for TURP devices, laser BPH devices, brachytherapy, urinary catheters, nephrostomy devices, urinary incontinence slings, stone treatment devices, urological endoscopes and erectile dysfunction devices. While each individual segment is expected to exhibit growth at varying levels, the overall market will continue to increase to meet a rising demand in urological procedures.

As a whole the urological device market is very well established. This limits potential for substantial growth. Although companies continue to provide novel adaptations to their products, the general trend within the market is a slightly declining ASP. However, some segments are an exception to this – lasers (for both BPH and stone management) have recently seen some exciting developments.

Although a highly commoditized market, an increasing global awareness of infection rates is helping to drive a single-use device preference. This results in higher unit sales and an associated growth in market value. Despite this preference, there is an ongoing push within the U.K. to gain acceptance of reusable catheters.

The shift within urological endoscopes from fiber devices to video devices is not complete and therefore the urological endoscope market should continue to exhibit strong growth for the near future. Additionally, the urinary catheter market is expected to exhibit strong growth, particularly hydrophilic catheters.

General Report Contents

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions

Report Specifics, New Content, Major Trends & Report Changes

Overall Reasons to Buy

  • Includes information on reimbursement changes across all chapters
  • In-depth re-evaluation of urinary catheter segment; a >€1 billion market
  • Analysis of US based lawsuits towards vaginal mesh products and international impact
  • In-depth analysis of market shift towards video scopes
  • In-depth analysis of market preferences for bipolar TURP vs laser based devices
  • In depth coverage of shift from monopolar to bipolar TURP units
  • Addition of urethral bulking subsection to further complement urinary incontinence device coverage *NEW*
  • Addition of ureteral stent placement procedure volume by country *NEW*
  • Addition of new prostate cancer procedures including: open and laparoscopic prostatectomy procedures, robotic prostatectomy procedures, watchful waiting, high intensity focused ultrasound (HIFU) procedures, brachytherapy procedures, high-dose-rate (HDR) procedures, external radiation therapy (primary) procedures and external radiation therapy (secondary) *NEW*
  • Addition of full market forecast for synthetic and non-synthetic female urinary incontinence slings *NEW*
  • Addition of competitive market share analysis by country for female urinary incontinence slings for 2015 AND 2016 *NEW*
  • Addition of Human Urinary System, Urinary Pathology and Disorders and Patient Demographics provides a more rounded view of the European urological devices market *NEW*
  • Addition of Product Portfolio provides enhanced clarity on precisely what products are captures in market forecasts *NEW*
  • Addition of Regulatory Issues & Recalls provides detailed overview of regulatory activity affecting the European urological devices market *NEW*
  • Addition of Clinical Trials section provides insight on recently completed, ongoing, and scheduled clinical trials affecting the European urological devices market *NEW*
  • Addition of SWOT analysis provides detailed view into the strengths, weaknesses, opportunities and threats of Coloplast, Wellspect Healthcare, Teleflex, Hollister, C. R. Bard and Boston Scientific *NEW*

Laser BPH 

  • Discussion of growth rates for unit sales, ASP and market value for laser BPH capital and fiber devices.
  • Analysis of impact of general purchasing models on fiber sales
  • Discussion of increasing preference for laser devices over TURP
  • Discussion of major market drivers and limiters

Brachytherapy 

  • Discussion of country distribution and preference for brachytherapy treatment
  • Data discussed on a per procedure cost analysis level
  • Analysis of Germany’s particular preference towards brachytherapy treatments
  • Discussion of ongoing drivers of brachytherapy market

Urinary Catheter 

  • Discussion of growth rates for unit sales, ASP and market value for intermittent, foley and male external urinary catheters
  • Analysis of shift towards home catheterizations and its market impact
  • In depth analysis of impact of CDC recommendations, group purchasing organizations and commoditization of catheter devices

Nephrostomy 

  • Discussion of growth rates for unit sales, ASP and market value for percutaneous nephrostomy acess kits, balloon dilators and nephrostomy tubes.
  • Analysis of impact of changing preferences for tubeless devices
  • Analysis of shift away from hospital to office based procedures.

Urinary Incontinence Sling 

  • In depth analysis of female and male incontinence sling markets
  • Discussion of potential international impact of FDA recommendations and US based lawsuits.
  • Analysis of major drivers and limiters of the sling market
  • Discussion of shift away from synthetic slings

Stone Treatment

  • Coverage of ESWL, holmium laser fibers, ureteral stents and stone retrieval devices.
  • Further segmented into retrieval basket and grasper; for both nitinol and stainless steel devices
  • Discussion of potential limiting factor of alternative drug treatments.
  • Major competitive analysis (10+ companies covered)

Urological Endoscope 

  • Highest segmented chapter
  • In depth coverage of both fiber and video devices for ureteroscopes and cystoscopes.
  • Analysis of shift away from fiber to video and associated market impact
  • Discussion of impact on urological endoscope sales due to shifting of urologists to hospital settings.

Erectile Dysfunction 

  • Discussion of growth rates for ASP, unit sales and market value for malleable and inflatable devices
  • Discussion of two-piece vs three-piece inflatable devices
  • Analysis of major drivers and limiters
The "European Market Report Suite for Urological Devices 2016 - MedSuite" includes analysis on the following companies currently active in this market: Coloplast Wellspect HealthCare Teleflex Hollister C. R. Bard Boston Scientific Karl Storz Olympus Manfred Sauer Lumenis Covidien Richard Wolf Cook Medical Dornier MedTech Eckert & Ziegler BEBIG GE Healthcare (Oncura) Others include: Ace Medical Devices, Ackermann, Advanced Shockwave Technology, Agency for Medical Innovations (A.M.I.), Allium Medical, Amecath, Apexmed International, Applied Medical, AprioMed, Aspide, Astora, B. Braun, Bactiguard, Best Medical, BioDerm, Biolitec, Boston Scientific, Caldera Medical, CL Medical, Convatec, Convergent Laser Technologies, Cook Medical, Cousin Biotech, Cure Medical, Direx, DynaMesh, EDAP TMS, Electro Medical Systems, Elekta, Ethicon, Helioscopie, IsoAid, Karl Storz, LocaMed, Medispec, MTS Medical, Neomedic International, Olympus, PercSys, Poiesis Medical, Promedon, Quanta Systems, ROCAMED, Siemens, Sopro-Comeg, Stahl Endoscopy, Stryker, Theragenics (BXT Accelyon), Trimedyne, Vygon, Zephyr Surgical Implants, etc. *Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Thank you!

CLOSE
Report Type Info

Single License: A single license is for use by a single individual only. Usage rights may not be transferred, sold or distributed by any means.

Site License: A site license allows sharing of the reports between various users within the purchasing company’s designated business address within this agreement.

Corporate License: A corporate license is for the use of one corporation. A corporation is defined as any business entity incorporated under a single name. Separate corporations operating under the same parent company are not included in this license.

Executive Summary: An in-depth summary of the reports associated with the related MedSuite product.

CLOSE

Login

Sign Up

Already have an account? Sign in

×